Kennel cough (also known as canine infectious tracheobronchitis) is an upper respiratory infection affecting dogs. There are multiple causative agents, the most common being the bacterium Bordetella bronchiseptica (found in 78.7% of cases in Southern Germany), followed by canine parainfluenza virus (37.7% of cases), and to a lesser extent canine coronavirus (9.8% of cases). It is highly contagious; however adult dogs may display immunity to reinfection even under constant exposure. Kennel cough is so named because the infection can spread quickly among dogs in the close quarters of a kennel or animal shelter.
Viral and bacterial causes of canine cough are spread through airborne droplets produced by sneezing and coughing. These agents also spread through contact with contaminated surfaces. Symptoms begin after a several day incubation period post-exposure, and in most cases will clear up on their own. However, in young puppies or immunocompromised animals, mixed or secondary infections can progress to lower respiratory infections such as pneumonia.
The incubation period is 5–7 days (with a range of 3–10). Symptoms can include a harsh, dry cough, retching, sneezing, snorting, gagging or vomiting in response to light pressing of the trachea or after excitement or exercise. The presence of a fever varies from case to case.
Although kennel cough is considered to be a multifactorial infection, there are two main forms. The first is more mild and is caused by B. bronchiseptica and canine parainfluenza virus infections, without complications from canine distemper virus (CDV) or canine adenovirus (CAV). This form occurs most regularly in autumn, and can be distinguished by symptoms such as a retching cough and vomiting. The second form has a more complex combination of causative organisms including CDV and CAV. It typically occurs in dogs that have not been vaccinated and it is not seasonal. Symptoms are more severe than the first form, and may include rhinitis, conjunctivitis, and fever in addition to a hacking cough.
Viral infections such as canine parainfluenza or canine coronavirus are only shed for roughly 1 week following recovery; however, respiratory infections involving Bordetella bronchiseptica can be transmissible for several weeks longer. While there was early evidence to suggest that B. bronchiseptica could be shed for many months post-infection, a more recent report places detectable nasal and pharyngeal levels of B. bronchiseptica in 45.6% of all clinically healthy dogs. This has potentially expanded the vector from currently or recently infected dogs to half the dog population as carriers. To put the relative levels of shedding bacteria into perspective, a study analyzing the shedding kinetics of B. bronchiseptica presents the highest levels of bacterial shedding one week post-exposure, with an order of magnitude decrease in shedding observed every week. This projection places negligible levels of shedding to be expected 6 weeks post-exposure (or ~5 weeks post-onset of symptoms). Dogs which had been administered intranasal vaccine 4 weeks prior to virulent B. bronchiseptica challenge displayed little to no bacterial shedding within 3 weeks of exposure to the virulent strain.
Treatment and prevention
Antibiotics are given to treat any bacterial infection present. Cough suppressants are used if the cough is not productive. Prevention is by vaccinating for canine adenovirus, distemper, parainfluenza, and Bordetella. In kennels, the best prevention is to keep all the cages disinfected. In some cases, such as "doggie daycares" or nontraditional playcare-type boarding environments, it is usually not a cleaning or disinfecting issue, but rather an airborne issue, as the dogs are in contact with each other's saliva and breath. Although most kennels require proof of vaccination, the vaccination is not a fail-safe preventative. Just like human influenza, even after receiving the vaccination, a dog can still contract mutated strains or less severe cases.
To increase their effectiveness, vaccines should be administered as soon as possible after a dog enters a high-risk area, such as a shelter. 10 to 14 days are required for partial immunity to develop. Administration of B. bronchiseptica and canine-parainfluenza vaccines may then be continued routinely, especially during outbreaks of kennel cough. There are several methods of administration, including parenteral and intranasal. However, the intranasal method has been recommended when exposure is imminent, due to a more rapid and localized protection. Several intranasal vaccines have been developed that contain canine adenovirus in addition to B bronchiseptica and canine-parainfluenza virus antigens. Studies have thus far not been able to determine which formula of vaccination is the most efficient. Adverse effects of vaccinations are mild, but the most common effect observed up to 30 days after administration is nasal discharge. Vaccinations are not always effective. In one study it was found that 43.3% of all dogs in the study population with respiratory disease had in fact been vaccinated.
Dogs will typically recover from kennel cough within a few weeks. However, secondary infections could lead to complications that could do more harm than the disease itself. Several opportunistic invaders have been recovered from the respiratory tracts of dogs with kennel cough, including Streptococcus, Pasteurella, Pseudomonas, and various coliforms. These bacteria have the potential to cause pneumonia or sepsis, which drastically increase the severity of the disease. These complications are evident in thoracic radiographic examinations. Findings will be mild in animals affected only by kennel cough, while those with complications may have evidence of segmental atelectasis and other severe side effects.
- Crawford, Cynda (September 26, 2005). "Media Briefing on Canine Influenza". Media Relations, Centers for Disease Control and Prevention. Retrieved 2012-01-24.
- Schulz, BS; Kurz, S; Weber, K; Balzer, HJ; Hartmann, K (September 2014). "Detection of respiratory viruses and Bordetella bronchiseptica in dogs with acute respiratory tract infections". Veterinary journal 201 (3): 365–369. doi:10.1016/j.tvjl.2014.04.019. PMID 24980809.
- Ettinger, Stephen J.; Feldman, Edward C. (1995). Textbook of Veterinary Internal Medicine (4th ed.). W.B. Saunders Company. ISBN 0-7216-6795-3.
- Bemis, DA; Carmichael, LE; Appel, MJ (April 1977). "Naturally occurring respiratory disease in a kennel caused by Bordetella bronchiseptica". The Cornell Veterinarian 67 (2): 282–293. PMID 870289.
- Sherding G., Robert (2006). Saunders Manual of Small Animal Practice (Third ed.). Saint Louis: W.B. Saunders. pp. 151–153. doi:10.1016/B0-72-160422-6/50014-0. ISBN 9780721604220.
- Thrusfield, M; Aitken, C; Muirhead, R (1991). "A Field Investigation of Kennel Cough: Incubation Period and Clinical Signs". Journal of Small Animal Practice 32: 215–220. doi:10.1111/j.1748-5827.1991.tb00550.x.
- Iemura, R; Tsukatani, R; Micallef, MJ; Taneno, A (26 December 2009). "Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica". The Veterinary record 165 (25): 747–751. PMID 20023279.
- Edinboro, C; Ward, M; Glickman, L (February 2004). "A Placebo-controlled Trial of Two Intranasal Vaccines to Prevent Tracheobronchitis (kennel Cough) in Dogs Entering a Humane Shelter". Preventive Veterinary Medicine.
- Thrusfield, M; Aitken, C; Muirhead, R (1989). "A Field Investigation of Kennel Cough: Efficacy of Vaccination". Journal of Small Animal Practice 30: 550–560. doi:10.1111/j.1748-5827.1989.tb01471.x.
- Schulz, B; Kurz, S; Balzer, H; Hartmann, K (September 2014). "Detection of Respiratory Viruses and Bordetella Bronchiseptica in Dogs with Acute Respiratory Tract Infections". The Veterinary Journal 201: 365–369. doi:10.1016/j.tvjl.2014.04.019. PMID 24980809.
- Greene, Craig E (2006). "6". Infectious Diseases in Dogs and Cats (third ed.). St Louis.